951322-11-5
951322-11-5 結(jié)構(gòu)式
基本信息
Deformylflustrabromine hydrochloride
6-Bromo-2-(1,1-dimethyl-2-propen-1-yl)-N-methyl-1H-indole-3-ethanamine hydrochloride
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2026/06/05 | HY-107675 | DEFORMYLFLUSTRABROMINE HYDROCHLORIDE Desformylflustrabromine hydrochloride | 951322-11-5 | 5 mg | 600元 |
| 2026/06/05 | HY-107675 | DEFORMYLFLUSTRABROMINE HYDROCHLORIDE Desformylflustrabromine hydrochloride | 951322-11-5 | 10 mM * 1 mL in DMSO | 660元 |
| 2026/06/05 | HY-107675 | DEFORMYLFLUSTRABROMINE HYDROCHLORIDE Desformylflustrabromine hydrochloride | 951322-11-5 | 10 mg | 950元 |
常見問題列表
α 4 β 2 nAChR
Desformylflustrabromine hydrochloride is a selective agonist of α 4 β 2 neuronal nicotinic acetylcholine receptor (nAChR) with a pEC 50 of 6.48. ACh-induced currents are potentiated and inhibited by Desformylflustrabromine hydrochloride in the high sensitivity (HS) and low sensitivity (LS) isoform preparations, although Desformylflustrabromine hydrochloride displays a higher potency on the LS isoform (pEC 50 =6.4±0.2) compare with the HS isoform (pEC 50 =5.6±0.2). Desformylflustrabromine hydrochloride potentiates ACh-induced responses of wild-type receptors expressed using the HS isoform preparation maximally by 350±20%, which is similar to receptors expressed via the LS isoform preparation (350±30%).